SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-21-002970
Filing Date
2021-07-14
Accepted
2021-07-14 15:51:15
Documents
38
Period of Report
2021-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cannabics_10q-053121.htm 10-Q 471134
2 CERTIFICATION cannabics_ex3101.htm EX-31.1 9543
3 CERTIFICATION cannabics_ex3102.htm EX-31.2 9704
4 CERTIFICATION cannabics_ex3201.htm EX-32.1 4972
5 CERTIFICATION cannabics_ex3202.htm EX-32.2 4788
6 GRAPHIC image1.jpg GRAPHIC 11343
7 GRAPHIC image2.jpg GRAPHIC 6570
8 GRAPHIC image3.jpg GRAPHIC 12731
9 GRAPHIC image4.jpg GRAPHIC 22064
  Complete submission text file 0001683168-21-002970.txt   1436493

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE cnbx-20210531.xml EX-101.INS 96737
11 XBRL SCHEMA FILE cnbx-20210531.xsd EX-101.SCH 12371
12 XBRL CALCULATION FILE cnbx-20210531_cal.xml EX-101.CAL 27867
13 XBRL DEFINITION FILE cnbx-20210531_def.xml EX-101.DEF 23054
14 XBRL LABEL FILE cnbx-20210531_lab.xml EX-101.LAB 112603
15 XBRL PRESENTATION FILE cnbx-20210531_pre.xml EX-101.PRE 81666
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52403 | Film No.: 211090226
SIC: 2834 Pharmaceutical Preparations